2,718 Results
Analytik Jena opens €96M German facilities, expanding lab instrumentation output that could ease procurement pressure for pharma QC labs.
CDER's new Exclusivity Board will oversee NCE, new clinical trial, and biologic exclusivity determinations to improve consistency across rulings.
Alcon's Brytly becomes the first nonprescription apraclonidine eye drop approved by FDA, signaling continued agency push on OTC drug access.
FDA confirms bacterial contamination in counterfeit eye drops from DLC Laboratories, ProMex, and Laboratorios Sophia found across six U.S. states.
EMA's CHMP issued six positive opinions in October 2026, including oral GLP-1 orforglipron and two biosimilars, with key implications for EU market entry.
Adial Pharmaceuticals names tapinarof architect David Rubenstein as Chief Scientist to lead AT177 through IND-enabling studies toward 2027 first-in-human trials.
Dermata Therapeutics reports topline cosmetic study data for Tome Foundational Treatment, with 71% of participants showing improvement after one application.